Comparison Between TICL and ICL+AK for High Myopic Astigmatism
Study Details
Study Description
Brief Summary
To compare the outcomes of a toric Implantable Collamer Lens (ICL) and a spherical Implantable Collamer Lens combined with astigmatic keratotomy (AK) in the correction of high myopic astigmatism.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Toric Implantable Collamer Lens Subjects in this group will implant Toric Implantable Collamer Lens for high myopic astigmatism |
Device: Toric Implantable Collamer Lens
uses Toric Implantable Collamer Lens implantation to correct the high myopic astigmatism.
|
Experimental: ICL+ Astigmatic keratotomy Subjects in this group will implant Implantable Collamer Lens and combined with astigmatic keratotomy for high myopic astigmatism |
Device: ICL + Astigmatic keratotomy
uses Implantable Collamer Lens implantation combined with Astigmatic keratotomy to correct the high myopic astigmatism
|
Outcome Measures
Primary Outcome Measures
- Uncorrected Visual Acuity (UCVA) at distance [2 years after surgery]
measured at 5 meter
- astigmatism [2 years after surgery]
astigmatism getting from subjective refraction
Secondary Outcome Measures
- Best Corrected Visual Acuity (BCVA) at distance [2 years after surgery]
subjective refraction
- Spherical Equivalent (SE) [2 years after surgery]
subjective refraction
- mean postoperative BCVA/mean preoperative BCVA [2 years after surgery]
safety index
- mean postoperative UCVA/mean preoperative BCVA [2 years after surgery]
efficacy index
Eligibility Criteria
Criteria
Inclusion Criteria:
-
age ranged from 18 to 40 years,
-
myopia greater than -8.00 diopters (D), and refractive cylinder in the range of 1.50D to 5.50D,
-
for the patients who were planned to undergo AK+ICL implantation, the axial difference between the corneal astigmatism and the manifest refractive astigmatism was less than 10 degree,
-
a stable refractive error during the previous 2 years,
-
anterior chamber depth more than 2.8 mm,
-
endothelial cell density (ECD) more than 2500 cells/mm2, and
-
scotopic pupillary diameter less than 7 mm.
Exclusion Criteria:
- subjects had significant irregular astigmatism, corneal pathological changes, glaucoma, ocular inflammation, or previous ocular trauma or surgery.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Wenzhou Medical University
Investigators
- Principal Investigator: AYong Yu, MD.PhD., Wenzhou Medical University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- TICL compare with ICL+AK